Medpace Holdings (MEDP) Tops Q4 EPS by 73c, provides guidance

Medpace Holdings (NASDAQ: MEDP) reported Q4 EPS of $3.67, $0.73 better than the analyst estimate of $2.94. Revenue for the quarter came in at $536.6 million versus the consensus estimate of $534.86 million.

GUIDANCE:

Medpace Holdings sees FY2025 revenue of $2.11-2.21 billion, versus the consensus of $2.238 billion. This guidance assumes a full year 2025 tax rate of 18.0% to 19.0%, interest income of $30.5 million, and 31.7 million diluted shares outstanding. This guidance does not include the potential impact of any share repurchases the Company may make pursuant to the share repurchase program after December 31, 2024.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.

You May Also Be Interested In

• Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
• Lucid reports Q2 output, names new CFO and five other leaders
• Tesla Q2 deliveries reach 480,126, topping estimates of 406,024